Anemia is one of the most common health problems in the primary care setting.
| INTRODUCTION
Anemia is one of the most commonly diagnosed conditions by primary care physicians. In 2010, global anemia prevalence was 32.9%, that is, more than 2.2 billion people were affected. 1 The World Health Organization (WHO) defines anemia as a hemoglobin (Hb) count of less than 13 g/L in men, less than 12 g/L in nonpregnant women, and less than 11 g/L in pregnant women and the elderly. The cause of anemia varies by age, sex, and geography, and iron-deficiency anemia is the most common etiology. 1 For differential diagnosis, it is useful to classify the type of anemia based on the red cell indices of Wintrobe, 2 which is calculated from red blood cell count, hemoglobin concentration, and hematocrit. The mean corpuscular volume (MCV) is calculated from hematocrit (%) × 10/RBC count (10 6 /μl), and macrocytic anemias are defined as MCV >100 fL.
Although macrocytic anemias are not frequently encountered by general physicians, a report from a family practice group found macrocytosis in 2%-4% of patients, 3 and a study of 1784 randomly selected older adults living at home found macrocytosis in 6.3% of men and 3.3% of women. 4 The causes of anemia in older adults are complicated because they often have multiple comorbidities. According to the Stanford study, hematologic malignancy and iron-deficiency anemia accounted for 22% and 12% of the older adult patients with anemia, respectively, and the etiology of anemia remained unknown in 35% of the patients. 5 With the expected future increase in the older population, it is likely that the number of cases of macrocytic anemia encountered by primary care physicians will increase. Thus, this review summarizes the diagnosis and treatment of macrocytic anemias in adults.
| ETIOLOGY
The cause of macrocytic anemia is classified into one of the following categories, megaloblastic or nonmegaloblastic. Megaloblastic anemia
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is caused by deficiency or impairment of utilization of vitamin B12 or folate. Nonmegaloblastic anemia may be the result of liver dysfunction, alcoholism, myelodysplastic syndrome (MDS), or hypothyroidism. In Finland, the common causes of macrocytic anemias were alcoholism (65%) 7 and vitamin B12 or folate deficiency (28%) 8 in outpatients over 75 years of age.
| VITAMIN B12 DEFICIENCY
Vitamin B12 deficiency is the most common cause of megaloblastic anemia. Vitamin B12 deficiency is caused by insufficient dietary intake, as in the cases of vegetarians or malnutrition, malabsorption due to the absence of intrinsic factor caused by pernicious anemia or following gastric surgery, congenital disorders, such as transcobalamin II deficiency, or exposure to nitrous oxide.
The result of one study, conducted in Japan, indicated that the most common cause of megaloblastic anemia is pernicious anemia (61%), followed by vitamin B12 deficiency due to gastrectomy (34%), vitamin B12 deficiency due to other causes (2%), and folate deficiency (2%). 9 Vitamin B12 is contained in animal foods, and the daily intake is approximately 3-30 μg. The daily required amount is approximately 1-3 μg, and except for stomach or intestinal obstruction, or being a strict vegetarian, vitamin B12 deficiency is rare.
Vitamin B12 binds to intrinsic factor secreted by the gastric parietal cells, and it is absorbed in the terminal ileum. Once absorbed, vitamin B12 acts as a coenzyme in the enzymatic reaction that produces methionine from homocysteine. As a result, folic acid is converted into its active form. When vitamin B12 is deficient, active folic acid is also deficient. As a result, the intracellular reaction involving the coenzyme form of folic acid is affected. Thus, not only vitamin B12 but also folate deficiencies impair DNA synthesis. Because a large amount of vitamin B12 is stored in the liver, it takes 5-10 years for clinical problems to manifest following decreased intake or absorption of vitamin B12.
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The signs and symptoms induced by megaloblastic anemia due to vitamin B12 deficiency are fatigue, headache, palpitations, and dyspnea, and neurological symptoms such as dysesthesia and hypoesthesia may also be present. In severe cases, ataxia, decreased pro- reported that oral treatment is effective, because 1%-5% of vitamin B12 absorption in the terminal ileum is by passive diffusion, which does not involve intrinsic factor.

| PERNICIOUS ANEMIA
Pernicious anemia accounts for 20%-50% of the vitamin B12 deficiency in adults, 11 and is associated with autoimmune gastritis, resulting in the destruction of gastric parietal cells and the associated lack of intrinsic factor. 12 The prevalence of pernicious anemia is estimated at 10-50 per 100 000 persons, among North Europeans 
| FOLATE DEFICIENCY
| MYELODYSPLASTIC SYNDROME
MDS is defined as a clonal hematopoietic stem cell disorder characterized by cytopenia, myelodysplasia, ineffective hematopoiesis, and increased risk of progression to acute myeloid leukemia (AML). 21 The prevalence in Japan is approximately 3 per 100 000 persons, and is increasing. In a study of 124 patients aged 75 years or older, with an elevated MCV (>95 fL), six patients were diagnosed with MDS. 
| ALCOHOLISM
Alcoholism is a well-known cause of macrocytic anemias. Chronic consumption of more than 80 grams of alcohol per day has adverse effects on the hematologic system. 23 Even before anemia develops, approximately 90% of alcoholics have macrocytosis (MCV between 100 and 110 fL). 24 Diagnosing alcoholism is often difficult, but the Michigan Alcoholism Screening test and γ-glutamyltransferase levels are found to be the two most sensitive tests for detecting alcoholism in patients with macrocytosis. 25 In patients with elevated MCV, it may be valuable to perform the above tests, taking into consideration the possibility of alcoholism. Abstinence from alcohol rapidly returns elevated MCV 26 to normal levels.
| HYPOTHYROIDISM
Anemia associated with hypothyroidism is usually normocytic or macrocytic. Because thyroid hormone stimulates the production of erythropoietin and affects hematopoiesis, a reduction in thyroid hormone production may cause anemia.
| DRUGS
Many drugs cause megaloblastic anemia by impairing the cellular availability or the utilization of folic acid or vitamin B12. This could be caused by interference with absorption, plasma transport, or delivery of folate or vitamin B12, competition for reducing enzymes, end-product inhibition of co-factor-mediated reactions, or physical destruction of the vitamins. 27 Common drugs that cause macrocytosis are hydroxyurea, methotrexate, zidovudine, azathioprine, antiretroviral agents, valproic acid, and phenytoin (Table 1) . If serum vitamin B12 levels are <200 pg/mL, vitamin B12 deficiency is very likely. 29 If serum vitamin B12 levels are >300 pg/mL, vitamin B12 deficiency is unlikely. reticulocyte volume is high. 33 Moreover, hyperglycemia, marked leukocytosis, and cold agglutinins cause spurious macrocytosis.
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Of importance is the indication for bone marrow examinations. This is recommended for patients with abnormal cells in blood circulation or patients who do not respond to treatments, such as vitamin replacement.
| CONCLUSIONS
Primary care physicians may encounter more cases of macrocytic anemias in the near future than they have over the past several decades, as the older population increases, because macrocytic anemias commonly appear in elderly patients. Although macrocytic anemias have many different etiologies, MDS is one of the leading causes of macrocytic anemias in the elderly, and clonal hematopoiesis with somatic mutations, similar to those of MDS patients, has been confirmed in 10% of persons over 65 years of age without apparent hematological disorders. 34 When the cause of anemia cannot be determined, in spite of the effort with noninvasive diagnostic tests and procedures, a consultation with a hematologist is recommended.
